Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of dexmedetomidine, lidocaine, magnesium sulfate, and fentanyl for cough suppression during tracheal tube removal
IRCT20141209020258N149Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine, lidocaine, fentanyl and magnesium sulfate in None (4 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Cough and Laryngospasm. Started Jun 2020; status: completed.
02
Drugs
dexmedetomidinelidocainefentanylmagnesium sulfate
Beyond the preview
Go deeper on IRCT20141209020258N149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N149.